TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Galapagos ( (GLPG) ) has shared an update.
On November 26, 2025, Galapagos NV announced that it received transparency notifications from Bank of America Corporation. These notifications indicated that Bank of America crossed the 5% threshold of Galapagos’ voting rights on November 12, 2025, following an acquisition, and then fell below this threshold on November 14, 2025, after disposing of these rights. This movement in voting rights reflects Bank of America’s dynamic involvement in Galapagos’ shares, which may impact the company’s shareholder structure and market perception.
The most recent analyst rating on (GLPG) stock is a Sell with a $22.00 price target. To see the full list of analyst forecasts on Galapagos stock, see the GLPG Stock Forecast page.
Spark’s Take on GLPG Stock
According to Spark, TipRanks’ AI Analyst, GLPG is a Neutral.
Galapagos’ overall stock score reflects a challenging financial and operational landscape. The company’s strong cash position and strategic partnerships are positive, but are overshadowed by significant operating losses, poor valuation metrics, and technical indicators suggesting potential downward pressure. Investors should be cautious and monitor the company’s ability to execute its strategic transformation and improve financial performance.
To see Spark’s full report on GLPG stock, click here.
More about Galapagos
Galapagos NV is a biotechnology company based in Mechelen, Belgium, focusing on the discovery and development of small molecule medicines. The company is listed on Euronext and NASDAQ under the ticker GLPG.
Average Trading Volume: 198,652
Technical Sentiment Signal: Sell
Current Market Cap: $2.04B
For a thorough assessment of GLPG stock, go to TipRanks’ Stock Analysis page.